Automating Pharma Validation: How to Unlock Efficiency & Reduce Risk
Bryan Ennis, Chief Quality Officer & Founder at Sware, and Dan Tummillo, Pharmaceutical Compliance Consultant at 2RR, have an insightful conversation about how pharmaceutical companies can harness automation to streamline validation processes, mitigate risks, and boost operational efficiency.
In this session, Bryan and Dan discuss the key challenges pharma companies face with scattered data, slow validation processes, and reactive compliance efforts. They also explore how automating pharma validation can reduce human error, enable proactive reporting, provide real-time data access, and drive smarter decision-making—ultimately improving compliance and continuous quality improvement.
Pharma leaders: don’t miss this opportunity to learn how automation can transform your validation processes and keep you ahead of evolving regulatory demands.
Featured Resources
The convergence of AI and Quality Management marks a paradigm shift in how Life Sciences organizations meet their GxP obligations. Examine key challenges—from compliance complexities and validation demands to talent shortages and risk management concerns.
Read the WhitepaperAs the life sciences landscape rapidly evolves, technology adoption demands agile validation methods to maintain GxP compliance. Learn how organizations can shift from project-based validation to a process-driven approach, integrating validation into their Quality Management System.
Read the WhitepaperManual computer software validation processes cost life sciences organizations up to 30% in additional project budget. As companies struggle to keep up with a surge of app and software integrations, they incur validation debt: the mounting cost of stretched resources, blanket testing, and missed GxP requirements.
Download the EbookValidation Debt Stops Here
If your organization is ready to embrace the future of life sciences validation, we’re ready to help.